Safety and Efficacy Study of Sotatercept in Adults With Transfusion Dependent Diamond Blackfan Anemia
Status:
Recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and dosing of drug Sotatercept, as a
subcutaneous injection, to stimulate production of red blood cell production. To be given
every 28 days for up to four doses.